课题基金 / 基金详情

Expression of cyclooxygenase (COX)-2 in head and neck cancer and inhibitory effect of COX-2 inhibitors on tumor growth

Expression of cyclooxygenase (COX)-2 in head and neck cancer and inhibitory effect of COX-2 inhibitors on tumor growth
环氧合酶(COX)-2在头颈癌中的表达及COX-2抑制剂对肿瘤生长的抑制作用
批准号:
12470453
负责人:
URADE Masahiro
金额:
$6.78万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2000
资助国家:
日本
项目状态:
已结题
起止时间:
2000 至 2002

项目摘要

项目成果

URADE Masahiro的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This study was designed to examine the immunohistochemical expression of cyclooxygenase (COX)-2 in head and neck cancer, and the inhibitory effect of COX-2 inhibitors on head and neck cancer cell growth. Based on the above experimental data, the chemopreventive potential of COX-2 inhibitors against DMBA-induced hamster cheek pouch carcinogenesis as animal model and synergistic effect of COX-2 inhibitors with anticancer agents as therapeutic strategy are also investigated. The results obtained were as follows.1) The immunohistchemical examination showed the expression of COX-2 protein n both squamous cell carcinoma (SCC) of the head and neck and salivary gland carcinoma (SGC). The expression rate was higher in SGC than SCC. In SCC, COX-2 expression became higher as the degree of tumor differentiation was lower, and undifferentiated carcinomas all showed high expression. In addition, metastatic lesions demonstrated significantly higher expression than primary lesions.2) The COX-2 express … More ion was shown not only in SCC but also in epithelial hyperplasia, epithelial dysplasia and carcinoma in situ. The extent of the expression was increased toward carcinogenesis. There was a close correlation between COX-2 expression and topoisomerase II α expression, and a tendency of poor prognosis in SCC patients with high expression of these enzymes.3) The COX-2 inhibitors inhibited the growth of head and neck cancer cell lines in a dose-dependent manner via apoptosis induction. These effects were more prominent in celecoxib than sulindac and etodolac. Celecoxib inhibited PGE_2 production and COX-2 expression efficiently.4) The non-cytotoxic or less cytotoxic concentrations of celecoxib augmented the growth inhibitory effect of anticancer agents such as adriamycin, vincristine and bleomycin by 2 to 10-fold via increased apoptosis induction.5) Oral administration of celecoxib retarded the onset of carcinoma formation, tumor growth and death in DMBA-induced hamster cheek pouch carcinogenesis model, although all hamsters developed SCC by DMBA application. Less
期刊论文(16)
专著(0)
科研奖励(0)
会议论文
Sakurai K., Urade M., Noguchi K., Kishimoto H., Ishibashi M., Yasoshima H., Yamamoto T., Kubota A.: "Increased expression of cyclooxygenase-2 in human salivary gland tumors"Pathology International. 51. 762-769 (2001)
Sakurai K.、Urade M.、Noguchi K.、Kishimoto H.、Ishibashi M.、Yasoshima H.、Yamamoto T.、Kubota A.:“人类唾液腺肿瘤中环氧合酶 2 的表达增加”国际病理学。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Hashitani S., Urade M., Nishimura N., Maeda T., Takaoka K., Noguchi K., Sakurai K.: "Apoptosis induction and enhancement of cytotoxicity of anticancer drugs by celecoxib, a selective cyclooxygenase-2 inhibitor, in human head and neck carcinoma cell lines"
Hashitani S.、Urade M.、Nishimura N.、Maeda T.、Takaoka K.、Noguchi K.、Sakurai K.:“塞来昔布(一种选择性环氧合酶 2 抑制剂)在人体中诱导细胞凋亡并增强抗癌药物的细胞毒性
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
櫻井一成, 黒田純子, 橋谷進, 西村則彦, 野口一馬, 岸本裕充, 浦出雅裕: "口腔扁平上皮癌の原発,転移巣におけるCyclooxygenase(COX)-2蛍日発現の比較検討"日本口腔科学会雑誌. 51巻6号. 366-373 (2002)
Kazunari Sakurai、Junko Kuroda、Susumu Hashitani、Norihiko Nishimura、Kazuma Noguchi、Hiromitsu Kishimoto、Masahiro Urade:“口腔鳞状细胞癌原发性和转移性病变中环氧合酶 (COX)-2 表达的比较研究”日本口腔学会科学杂志学会。第 51 卷,第 6 期。366-373 (2002)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Hashitani S., Urade M., Nishimura N., Maeda T., Takaoka K., Noguchi K. and Sakurai K.: "Apoptosis induction and enhancement of cytotoxicity of anticancer drugs by celecoxib, a selective cyclooxygenase-2 inhibitor, in human head and neck carcinoma cell lin
Hashitani S.、Urade M.、Nishimura N.、Maeda T.、Takaoka K.、Noguchi K. 和 Sakurai K.:“塞来昔布(一种选择性环氧合酶 2 抑制剂)在人体中诱导细胞凋亡并增强抗癌药物的细胞毒性
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
8
    Isolation and identification of oral cancer stem cells and development of specific therapy for cancer stem cells
    • 批准号:
      21390544
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.65万
    • 财政年份:
      2009
    • 负责人:
      URADE Masahiro
    • 依托单位:
    Analysis of mechanisms of oral cancer metastasis via chemokine signals and molecular target therapy for inhibition of metastasis
    • 批准号:
      18390549
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.03万
    • 财政年份:
      2006
    • 负责人:
      URADE Masahiro
    • 依托单位:
    Study on the inhibition of chemical carcinogenesis of buccal mucosa with a macrophage activating factor
    • 批准号:
      09672086
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.92万
    • 财政年份:
      1997
    • 负责人:
      URADE Masahiro
    • 依托单位:
    Study on the antitumor arug resistance in oral squamous carcinoma cells-Analysis of resistance mechanism and development of therapy for overcoming o the resistance-
    • 批准号:
      07457502
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $3.71万
    • 财政年份:
      1995
    • 负责人:
      URADE Masahiro
    • 依托单位:
    海外基金